Current Report Filing (8-k)
November 14 2016 - 5:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported)
|
|
November 9, 2016
|
Accelerate
Diagnostics, Inc.
(Exact name of registrant as specified in
its charter)
Delaware
(State or other jurisdiction of incorporation)
001-31822
|
84-1072256
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
3950 South Country Club, Suite 470, Tucson, Arizona
|
85714
|
(Address of principal executive offices)
|
(Zip Code)
|
(520)
365-3100
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed
since last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (
see
General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01
|
Regulation FD Disclosure.
|
On November 9,
2016, Accelerate Diagnostics, Inc. (the “Company”) hosted a conference call to discuss its results of operations for
the quarter ended September 30, 2016. A copy of the transcript of the conference call is attached hereto as Exhibit 99.1.
In accordance with
General Instruction B.2 for Form 8-K, the information in this Form 8-K, including Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
99.1
|
|
Earnings Call Transcript, November 9, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 14, 2016
|
ACCELERATE DIAGNOSTICS, INC.
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
/s/ Steve Reichling
|
|
|
Steve Reichling
|
|
Chief Financial Officer
|
EXHIBIT INDEX
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
99.1
|
|
Earnings Call Transcript, November 9, 2016
|
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Sep 2023 to Sep 2024